Market revenue in 2023 | USD 322.2 million |
Market revenue in 2030 | USD 765.5 million |
Growth rate | 13.2% (CAGR from 2023 to 2030) |
Largest segment | Genetic tests |
Fastest growing segment | Direct to Consumer Tests |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Genetic Tests, Direct to Consumer Tests, Esoteric Tests |
Key market players worldwide | Abbott Laboratories, Roche Holding AG, Siemens Healthineers AG ADR, Thermo Fisher Scientific Inc, BioMerieux SA, Becton Dickinson & Co, Danaher Corp, Qiagen NV, Hologic Inc, Agilent Technologies Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to precision diagnostics market will help companies and investors design strategic landscapes.
Genetic tests was the largest segment with a revenue share of 58.1% in 2023. Horizon Databook has segmented the Middle East & Africa precision diagnostics market based on genetic tests, direct to consumer tests, esoteric tests covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa precision diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa precision diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account